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 Peter Hotez, MD, PhD, FASTMH, FAAP 
•  One billion people treated for a neglected 
tropical disease in 2015, including 114 
million for river blindness. 
•  Very close to global eradication of Guinea 
worm disease:  
–  3.5 million human cases in 1986 
–  25 reported cases in 2016 
•  Sleeping sickness cases:  
–  37,000 new diagnoses in 1999  





•  Capitalizes on research 
strengths of the 5 UMass-
campuses 
•  Provides cores, services, 
funding to catalyze trans-
disciplinary collaborations and 
to create product pipelines 
•  Creates new training 
opportunities 










Molecular profiling: mechanistic 
understanding of disease 
By fostering collaboration and trans-disciplinary science, the UMass  













































2008-2010 (n=31 authors) 2008-2011 (n=210 authors) 2008-2012 (n=329 authors) 
2008-2013 (n=888 authors) 2008-2015 (n=1439 authors) 2008-2016 (n=1550 authors) 
UMCCTS Co-Author Network Growth: 2008 - 2016 
The Health System as a Learning Lab 
PaPent	Care	and	PopulaPon	Health	 Research	&	EducaPon	
Collaborative Support for Health System and Communities as 
Learning Labs for:   
•  Research 
•  Improvement (Quality, Efficiency, Cost) 
•  Clinical & Translational Science 
•  Education 
•  Health systems strengthening and Public Health 
Achieved through collaboration on: 
•  Data Lake (integrates clinical/research  data) 
•  Clinical Research Support 















& Analytics   
EPIC 
Clinical Trials Management System 
Data 
Lake 
Vision: Build an Integrative 
Clinical and Biospecimen 
Data Ecosystem to: 
•  Enable data driven 
research 
•  Enable translation of 
research findings to 
clinical care 
•  Make a difference in 
community and global 
health 
Clinical and Translational Research Data Ecosystem  
D3Health: Integrating Biomedical Big Data, 



























































Data from Remote/Sensors 
is integrated with clinical data 
Knowledge is generated and 









Leverages the engineering and business strengths of UML, along with the clinical and 
biomedical research strengths of UMMS to provide early stage inventors and 
established MA companies with easy, affordable access to services that move new 
medical devices from concept to production 
 
 Founded 2008 with ~$5M University and State Funds  
Ø Services: Assisted > 100 medical device companies to raise ~ $77M in 
private investment funds and $9.6 million in grants, 97 interns  
Ø Facilities: Two incubators currently host 22 client companies in a 
combination of wet lab, open collaboration, and office space 
Ø Funding: Annual new venture competition 
Ø $75M in economic development in 2014 
Ø ** NEW UMMS INCUBATOR – FALL 2017** 
 
Diabetes Innovation Challenge 
•  Partnership: M2D2 and T1D 
Exchange (Type 1 diabetes 
patient group) 
  
•  60+ applications from around 
the world 
•  Sponsors: ADA, JDRF, 
Medtronic, Lilly, J&J 
Innovation, Becton Dickinson, 
Law and Accounting firms	
•  Early stage winner: Integrated 
Medical (Irvine, CA) Fully-
integrated, low cost, implantable, 
wireless, continuous glucose 
monitoring platform 
 
•  Late stage winner: Enable 
Biosciences (San Francisco, CA)   
Ultrasensitive non-radioactive 
autoantibody test that can be 
readily used for population 
screening	
MASSBIOLOGICS OF UMMS 
 
Mission: “Medicine for Better Lives” 
 
For >100 years, MassBiologics has 
worked to improve public health 
through applied research, 
development, production, and 
clinical testing of biologic products. 
Only non-profit, FDA-licensed 
vaccine manufacturer in the United 
States 
•  Incubator for innovation and 
improvement in the processes of 
vaccine and biologics development  
•  Recently approved products 
o  Zinplava: reduction of recurrent C. 
diff in adults on antibiotics at high 
risk for C. diff recurrence 
o  Rabishield: rabies Mab 
•  New grants: NCATS preferred 
contractor 
•  National Institute for Innovation in 
Manufacturing Biopharmaceuticals 
(NIIMBL) 
Global Impact  
•  Isolation of Ebola antibodies 
from survivor (Mass 
Biologics; Science, 2016) 
•  Public heath lab capacity in 
Liberia (Paul Allen, CDC: 
$27.5M) 
–  Liberia’s Men’s Health 
Screening Program 
(MHSP): 10% of male 
Ebola survivors harbor 
RNA in semen; can persist 
up to 565 days 
–  First large scale GMP 
plasmapheresis facility in 
Africa (Grifols) 
UMCCTS Mentored Career Development and 
Clinical Research Scholar (K) Awardees 
•  Founded in 2007: 12 supported  
•  33 successful grant applications (80%) 
•  $40,207,226 total awarded 
•  381 Peer-Reviewed Publications  
•  100% of K graduates still active in Clinical 
and Translational Science 
Nancy Byatt, DO, MS, MBA 
Associate Professor, Psychiatry and OBGYN 
•  2013: CCTS K Award, Rapid Access to Perinatal 
Psychiatric Care in Depression (RAPPID) 
•  2014: Founding Medical Director, Massachusetts Child 
Psychiatry Access Program for Moms (MCPAP for 
Moms) 
•  2015: U01 award – 1 in the nation – RAPPID: an 
Innovative Stepped-Care Approach for Obstetrics and 
Gynecology Clinics 
•  2016: 21st Century Cures Bill appropriates $5M for 5 
states to develop  a program similar to  MCPAP for 






U01 - Strengthening Translational Research through Diverse Enrollment 
(STRIDE) award (Lemon and Allison; UMMS, Harris-Vanderbilt, Saag-UAB) 
Admin Supplement - I-Corps at NCATS  (Hafer; UMMS, Rockefeller, UAB, 
GA Tech, Penn State, UC Davis, Colorado, Michigan, Miami) 
 
Awaiting Funding:  
U01 - Translating Research Into Practice (TRIP): A Massachusetts 
Community Collaborative to Eliminate Persistent Health Disparities (Lemon; 
UMMS, Battaglia-BU, Freund-Tufts, Haas-Harvard) 
 
Under Review: 
U01 - Individual Development Plans for Clinical and Translational Scientists 
in Training: Defining Best Practices (Fuhrmann, Keaney, Allison, and Hafer; 
UMMS with 20+ Centers) 
Admin Supplement - Multi-CTSA mini-Sabbatical Evaluation and QUality 






















Look for themed 
table tents (or add 
your own) and join 















Center for Autonomous Chemistry (led by UMA) 
Center for Smart and Connected Society (led by 
UMA) 
Probiotic Discovery Engineering and 
Manufacturing Pipeline (UMD) 
UMass Consortium for Research on Imaging and 
Informatics (UML) 
UMass MOVEment Research Center: Exploring 
the Mechanics of Movement and Muscle 
Function (UML) 
 
